MX358625B - Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos. - Google Patents

Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Info

Publication number
MX358625B
MX358625B MX2018003025A MX2018003025A MX358625B MX 358625 B MX358625 B MX 358625B MX 2018003025 A MX2018003025 A MX 2018003025A MX 2018003025 A MX2018003025 A MX 2018003025A MX 358625 B MX358625 B MX 358625B
Authority
MX
Mexico
Prior art keywords
making
methods
regenerated cellulose
oxidized regenerated
hemostatic powders
Prior art date
Application number
MX2018003025A
Other languages
English (en)
Inventor
Yi-Lan Wang
Guanghui Zhang
Original Assignee
Ethicon Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48537032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX358625(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethicon Incorporated filed Critical Ethicon Incorporated
Publication of MX358625B publication Critical patent/MX358625B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)

Abstract

La presente invención está dirigida a un material hemostático que contiene polvo de ORC compactado que comprende partículas que tienen una relación de aspecto promedio de aproximadamente 1 a aproximadamente 18, en donde el polvo de ORC compactado, preferentemente, se procesó en un dispositivo de compactación, tal como un polvo de ORC molido con molino de bolas; la presente invención se refiere, además, a métodos para fabricar el material hemostático y a un método para tratar una herida mediante la aplicación del polvo hemostático sobre y/o en la herida de un paciente.
MX2018003025A 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos. MX358625B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/480,842 US8815832B2 (en) 2012-05-25 2012-05-25 Oxidized regenerated cellulose hemostatic powders and methods of making
PCT/US2013/042149 WO2013177242A1 (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making

Publications (1)

Publication Number Publication Date
MX358625B true MX358625B (es) 2018-08-28

Family

ID=48537032

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014014322A MX354596B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.
MX2018003025A MX358625B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014014322A MX354596B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Country Status (16)

Country Link
US (2) US8815832B2 (es)
EP (3) EP3466455B1 (es)
JP (1) JP6165849B2 (es)
KR (2) KR102254305B1 (es)
CN (1) CN104321085B (es)
AU (1) AU2013266416B2 (es)
BR (2) BR122019014998B1 (es)
CA (2) CA3094664C (es)
DK (1) DK3466455T3 (es)
ES (2) ES2702714T3 (es)
IL (2) IL235549B (es)
IN (1) IN2014DN09514A (es)
MX (2) MX354596B (es)
RU (2) RU2696575C2 (es)
WO (1) WO2013177242A1 (es)
ZA (1) ZA201409429B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102844053B (zh) 2009-11-25 2015-08-05 洛马林达大学医学中心 基于壳聚糖的止血织物
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
WO2016011315A1 (en) * 2014-07-18 2016-01-21 Ethicon, Inc. Combination cellulose material and method of making and using same
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
JP6926101B2 (ja) * 2015-11-06 2021-08-25 エシコン・インコーポレイテッドＥｔｈｉｃｏｎ， Ｉｎｃ． 圧密止血セルロース系凝集体
MX2018005783A (es) * 2015-11-08 2019-04-04 Omrix Biopharmaceuticals Ltd Composicion hemostatica.
AU2016350051B2 (en) * 2015-11-08 2020-11-19 Ethicon, Inc. Hemostatic mixture of cellulose-based short and long fibers
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
US20220111020A1 (en) * 2016-08-15 2022-04-14 Guangzhou Bioseal Biotech Co. Ltd. Hemostatic compositions and methods of making thereof
KR102656226B1 (ko) * 2016-12-09 2024-04-09 한국생산기술연구원 칼슘 카르복시메틸 셀룰로오스 파우더 및 수용성 키토산 화합물 파우더를 포함하는 지혈 소재 및 그의 제조 방법
RU2660582C1 (ru) * 2017-07-12 2018-07-06 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Гемостатическое покрытие в форме порошка
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US11007299B2 (en) 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
IL262716A (en) * 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
US11241386B2 (en) * 2019-02-13 2022-02-08 Biolife, L.L.C. Wound sealing powder
EP3996758B1 (en) 2019-07-12 2023-07-26 Cilag GmbH International Haemostatic powder
WO2021014357A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Collagen-based biomaterials for wound management
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
KR20210052099A (ko) * 2019-10-31 2021-05-10 주식회사 삼양바이오팜 분말형 지혈제 조성물 및 이의 제조 방법
CN113117131B (zh) * 2019-12-31 2023-01-03 广州迈普再生医学科技股份有限公司 一种纳米纤维微球材料及其制备方法和应用
CN113117132B (zh) * 2019-12-31 2022-11-22 广州迈普再生医学科技股份有限公司 一种可吸收膨胀式纳米短纤维粉状材料及其制备方法和应用
CN113117133B (zh) * 2019-12-31 2023-03-14 广州迈普再生医学科技股份有限公司 一种纤维聚集体及其制备方法和应用
AU2021257269A1 (en) * 2020-04-17 2022-10-27 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
RU2756316C1 (ru) * 2020-06-15 2021-09-29 Федеральное государственное бюджетное учреждение науки Байкальский институт природопользования Сибирского отделения Российской академии наук (БИП СО РАН) Местное гемостатическое антибактериальное средство, способ его получения и медицинское изделие на его основе
US20220023491A1 (en) * 2020-07-21 2022-01-27 Ethicon, Inc. Hemostatic Composite Aggregate Materials Having Surface Enriched with Hemostatis
CN114681660B (zh) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 可吸收止血粉及其制备方法和应用
MX2023008169A (es) 2021-01-08 2023-09-12 Cilag Gmbh Int Polvo sellador biorreabsorbible.
US20240148933A1 (en) 2022-11-08 2024-05-09 Ethicon, Inc. Expandable hemostatic tablets comprising oxidized regenerated cellulose

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5696191A (en) 1989-09-18 1997-12-09 Kimberly-Clark Worldwide, Inc. Surface-segregatable compositions and nonwoven webs prepared therefrom
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
JP3287798B2 (ja) 1997-12-17 2002-06-04 レンゴー株式会社 球状セルロース微粒子の製造方法
RU2146264C1 (ru) * 1998-08-10 2000-03-10 Институт эколого-технологических проблем Способ получения высокоокисленной целлюлозы и высокоокисленная целлюлоза "биоакцеллин"
GB2354708B (en) 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
US6627749B1 (en) 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6652840B1 (en) 2001-02-21 2003-11-25 Terence Prevendar Bleeding control and healing aid compositions and methods of use
US20030124087A1 (en) 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
US20070141156A1 (en) * 2005-12-21 2007-06-21 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20080027365A1 (en) 2006-06-01 2008-01-31 Huey Raymond J Hemostatic device with oxidized cellulose pad
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
JP5031054B2 (ja) * 2010-03-18 2012-09-19 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース及びこれを含む固形製剤
US10022410B2 (en) 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
WO2013039070A1 (ja) 2011-09-12 2013-03-21 グンゼ株式会社 親水性化セルロース繊維の製造方法
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
WO2016011315A1 (en) 2014-07-18 2016-01-21 Ethicon, Inc. Combination cellulose material and method of making and using same
JP6926101B2 (ja) 2015-11-06 2021-08-25 エシコン・インコーポレイテッドＥｔｈｉｃｏｎ， Ｉｎｃ． 圧密止血セルロース系凝集体

Also Published As

Publication number Publication date
ES2906971T3 (es) 2022-04-21
KR102254305B1 (ko) 2021-05-24
IL235549B (en) 2020-03-31
KR20150015517A (ko) 2015-02-10
US9539358B2 (en) 2017-01-10
RU2696575C2 (ru) 2019-08-05
CA2874622A1 (en) 2013-11-28
JP2015517388A (ja) 2015-06-22
US20140329769A1 (en) 2014-11-06
EP4043042A1 (en) 2022-08-17
CN104321085B (zh) 2017-06-23
MX354596B (es) 2018-03-12
IL261869A (en) 2018-10-31
CN104321085A (zh) 2015-01-28
AU2013266416A1 (en) 2014-11-27
ES2702714T3 (es) 2019-03-05
CA3094664C (en) 2023-06-06
RU2017128652A3 (es) 2019-05-28
IN2014DN09514A (es) 2015-07-17
RU2014152706A (ru) 2016-07-20
BR112014029206B1 (pt) 2019-11-26
US8815832B2 (en) 2014-08-26
DK3466455T3 (da) 2022-03-14
RU2017128652A (ru) 2019-02-04
JP6165849B2 (ja) 2017-07-19
EP2854882B1 (en) 2018-10-31
ZA201409429B (en) 2017-04-26
BR122019014998B1 (pt) 2020-01-28
WO2013177242A1 (en) 2013-11-28
AU2013266416B2 (en) 2016-03-24
IL235549A0 (en) 2015-01-29
BR112014029206A2 (pt) 2017-06-27
US20130316974A1 (en) 2013-11-28
CA3094664A1 (en) 2013-11-28
KR102131601B1 (ko) 2020-07-09
KR20200085904A (ko) 2020-07-15
IL261869B (en) 2020-07-30
EP2854882A1 (en) 2015-04-08
RU2629199C2 (ru) 2017-08-25
CA2874622C (en) 2021-03-09
EP3466455B1 (en) 2022-01-19
EP3466455A1 (en) 2019-04-10
MX2014014322A (es) 2015-02-12

Similar Documents

Publication Publication Date Title
MX358625B (es) Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.
MX2021007903A (es) Productos de insectos y metodos para fabricarlos y utilizarlos.
MY179872A (en) Method for the production of commercial nanoparticle and microparticle powders
PH12013501245A1 (en) Smoke filters for smoking devices with porous masses having a carbon particle loading and an encapsulated pressure drop
MY169154A (en) Tobacco material, tobacco product to which tobacco material is added, and method for producing tobacco material
MX2016008161A (es) Metodos para dar forma a material fibroso y composiciones de tratamiento para este.
MX359475B (es) Composiciones antitranspirantes y desodorantes.
MX2016004530A (es) Rapamicina para el tratamiento de linfangioleiomiomatosis.
NZ630367A (en) Methods of treatment of pediatric solid tumor
MX2015013845A (es) Polvos secos de tiotropio.
IN2014DN11169A (es)
MX2016008266A (es) Sustancias químicas aromáticas novedosas.
UA110845C2 (uk) Спосіб одержання адсорбентної частинки, яка несе ароматизатор
MX2017006545A (es) Proceso para la preparacion de 1-(2,6,6-trimetilciclohexil)-alcan- 3-oles.
MX2017008168A (es) 1-(7,10,10-trimetil-4-biciclo [6.2.0]decanil) etanona como producto quimico aromatico novedoso.
MY169808A (en) Plant powder-containing white chocolate-impregnated food and method for producing same
WO2011089130A3 (de) Verfahren zur herstellung von hohlkörpern mit eingeschlossenen frei beweglichen partikeln
MX2018003288A (es) Sistema y metodo para controlar la aspereza de las formulaciones en polvo seco basadas en nicotina.
NZ706983A (en) Treating soluble coffee
MY165035A (en) Wound spray
MX366277B (es) Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.
MX2017002029A (es) Composiciones de profarmacos de aripiprazol.
MX2016000671A (es) Articulo para fumar que tiene una envoltura que contiene particulas.
MY190070A (en) Method for producing a highly porous fine powdered slaked lime composition, and product obtained therefrom
EP3357482A4 (en) Composite powder in which porous polymer is impregnated with scoria powder particles, cosmetic composition containing same, and process for producing same